Objective:

To analyze the role of LYN gene mutations in breast cancer and their potential association with CNS metastasis, emphasizing the significance of these mutations in understanding disease progression.

Key Findings:

• LYN alterations, including copy-number changes and rare mutations, may influence breast cancer behavior and CNS metastasis, highlighting the need for targeted research.
• Most LYN mutations in breast cancer are heterogeneous and lack definitive functional annotation, which complicates their clinical application.
• No approved LYN-targeted therapies exist for breast cancer, indicating a critical need for biomarker-guided treatment strategies to improve patient outcomes.

Interpretation:

The study suggests that LYN mutations may play a role in the mechanisms of CNS metastasis in breast cancer, but further research is needed to clarify their functional impact and therapeutic potential, particularly in developing targeted therapies.

Limitations:

• The clinical relevance of specific LYN variants in breast cancer remains undefined, which limits the ability to tailor treatments.
• Most identified mutations lack functional characterization, limiting their clinical applicability and understanding of their role in disease progression.

Conclusion:

Understanding LYN's role in breast cancer and CNS metastasis could lead to better-targeted therapies and improved patient outcomes, underscoring the urgency for further research in this area.